6BFS
The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
| Synchrotron site | Australian Synchrotron |
| Beamline | MX2 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2015-07-03 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 0.954 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 70.454, 48.129, 77.602 |
| Unit cell angles | 90.00, 99.86, 90.00 |
Refinement procedure
| Resolution | 40.000 - 2.000 |
| R-factor | 0.185 |
| Rwork | 0.182 |
| R-free | 0.24800 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 1rjl |
| RMSD bond length | 0.017 |
| RMSD bond angle | 1.842 |
| Data scaling software | Aimless (0.5.4) |
| Phasing software | PHASER (2.5.7) |
| Refinement software | REFMAC (5.8.0107) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 40.000 | 39.550 | 2.050 |
| High resolution limit [Å] | 2.000 | 8.950 | 2.000 |
| Rmerge | 0.074 | 0.031 | 0.613 |
| Rmeas | 0.087 | 0.037 | 0.714 |
| Rpim | 0.045 | 0.019 | 0.365 |
| Number of reflections | 34696 | 421 | 2557 |
| <I/σ(I)> | 12 | ||
| Completeness [%] | 99.4 | 98.4 | 99 |
| Redundancy | 3.7 | 3.4 | 3.8 |
| CC(1/2) | 0.998 | 0.998 | 0.772 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 283.15 | 0. 2 M Sodium Chloride, 20% PEG 8000, 0.1 M phosphate Citrate 4.5 |






